Southbourne Surgery works closely with the Primary Care Research Network (PCRN) to participate in high quality medical research projects which are relevant to GP practice.
We have achieved level 3 (highest level) of the 'Research Ready' toolkit which has been developed in conjunction with the National Institute for Health Research (NIHR) and the PCRN, covering the requirements of the Research Governance Framework for undertaking primary care research in the UK.
Research can take various forms within the surgery, such as simply asking for questionnaires to be filled in, or they may involve coming into the surgery to see a doctor or nurse. You may be asked by the surgery staff if you would like to participate, or you may receive letters through the post informing you of our projects. If you do not wish to receive any research information by post, please inform us by email firstname.lastname@example.org so that we can note your preference.
Please note that in all cases, there is no obligation for any patients to participate in studies and it will not adversely affect your care whether or not you decide to take part. If you join a research study you may change your mind at any stage and withdraw.
Dr Pippa Lally is our Lead Research Investigator
Ginny Linscott is our Lead Research Nurse
Helen Yoward is our Administrative Research Manager
(please contact Helen in the first instance with any queries)
Thank you to those parents who allowed their children to participate in the above research. We are please to inform you that the paper 'Child-Parent Familial Hypercholesterolemia Screening in Primary Care' has been published in the New England Journal of Medicine in 27th October 2016.
The results show that child-parent screening for familial hypercholesterolemia is effective, feasible and acceptable on a national scale. There is now an opportunity for the NHS and other health agencies to consider offering child-parent screening routinely.
This is a data collection study to find out which symptoms and examinations are most effective in predicting lung or colon cancers. The inclusion criteria are all patients aged 35 years or over with lung symptoms for more that 3 weeks or bowel symptoms for any duration. Exclusions to the study are pregnancy, known malignancy (cancer) or terminal illness. If you would like to read more information on the CANDID Study please click here.
The target number of patients to recruit - 40
End recruitment date - Oct 2017